Hess Midstream Partners LP HESM 深 滬
已收盤 09-19 16:00:00 美东时间
35.36
-4.120
-10.44%
華盛通- 最 高36.82
- 今 開35.85
- 成交量 683.58万股
- 最 低 35.235
- 昨 收 39.48
- 總市值 46.32亿
- 52周最高 43.403
- 市盈率 靜 14.11
- 換手率 5.22%
- 52周最低 31.2874
- 委 比 5.82%
- 總股本 1.31亿
- 歷史最高 43.403
- 量 比 6.14
- 振 幅 4.01%
- 歷史最低 -6.8673
- 每 手 1
- 風險率 2.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Wells Fargo Downgrades Hess Midstream to Equal-Weight, Lowers Price Target to $39
Wells Fargo analyst Praneeth Satish downgrades Hess Midstream (NYSE:HESM) from Overweight to Equal-Weight and lowers the price target from $48 to $39.
09-19 20:41
Hess Midstream trims growth plans as Chevron cuts Bakken rigs
Hess Midstream (NYSE:HESM) -1.9% post-market Thursday after providing updated guidance for the rest of FY 2025 based on updated expectations, and for 2026-27 based on an expected decrease in Bakken ri...
09-19 04:56
美股大行评级 | 潜在涨幅208.48%！HC Wainwright & Co.上调Microbot Medical目标价至12美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Microbot Medical"买入"评级，目标价从9美元升至12美元；Maxim Group：维持Neuphoria Therapeutics"买入"评级，目标价从18美元升至35美元
09-12 12:53
Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a comple...
09-11 20:08
美股大行评级 | 最高400美元！大行纷纷连夜上调甲骨文目标价；新思科技则惨遭多家大行下调目标价
今日重点评级关注：瑞银：上调Gossamer Bio评级至"买入"，目标价从1.25美元升至9美元；Canaccord Genuity：维持Corcept Therapeutics"买入"评级，目标价从137美元升至140美元
09-11 10:06
UBS Downgrades Hess Midstream to Neutral, Lowers Price Target to $43
UBS analyst Manav Gupta downgrades Hess Midstream (NYSE:HESM) from Buy to Neutral and lowers the price target from $45 to $43.
09-10 18:51
Hess Midstream Partners Announces Leadership Change
Hess Midstream Partners ( ($HESM) ) has shared an announcement. On September 4,...
09-06 04:51
Demystifying Hess Midstream: Insights From 4 Analyst Reviews
Across the recent three months, 4 analysts have shared their insights on Hess M...
08-23 02:01
JP Morgan Maintains Neutral on Hess Midstream, Raises Price Target to $46
JP Morgan analyst Jeremy Tonet maintains Hess Midstream (NYSE:HESM) with a Neutral and raises the price target from $44 to $46.
08-22 22:16
Hess Midstream Announces $100 Million Repurchase Agreement
Hess Midstream Partners ( ($HESM) ) has issued an update. On August 4, 2025, He...
08-07 05:50
